Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.58
MCK's Cash to Debt is ranked lower than
56% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.71 vs. MCK: 0.58 )
Ranked among companies with meaningful Cash to Debt only.
MCK' s 10-Year Cash to Debt Range
Min: 0.05  Med: 0.52 Max: 3.01
Current: 0.58
0.05
3.01
Equity to Asset 0.16
MCK's Equity to Asset is ranked lower than
83% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.43 vs. MCK: 0.16 )
Ranked among companies with meaningful Equity to Asset only.
MCK' s 10-Year Equity to Asset Range
Min: 0.15  Med: 0.27 Max: 0.35
Current: 0.16
0.15
0.35
Interest Coverage 7.94
MCK's Interest Coverage is ranked lower than
73% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 79.78 vs. MCK: 7.94 )
Ranked among companies with meaningful Interest Coverage only.
MCK' s 10-Year Interest Coverage Range
Min: 0.94  Med: 8.13 Max: 12.77
Current: 7.94
0.94
12.77
F-Score: 6
Z-Score: 4.47
M-Score: -2.60
WACC vs ROIC
6.59%
15.55%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 1.76
MCK's Operating margin (%) is ranked lower than
66% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.04 vs. MCK: 1.76 )
Ranked among companies with meaningful Operating margin (%) only.
MCK' s 10-Year Operating margin (%) Range
Min: -0.27  Med: 1.43 Max: 2.54
Current: 1.76
-0.27
2.54
Net-margin (%) 0.90
MCK's Net-margin (%) is ranked lower than
71% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.85 vs. MCK: 0.90 )
Ranked among companies with meaningful Net-margin (%) only.
MCK' s 10-Year Net-margin (%) Range
Min: -0.2  Med: 0.97 Max: 1.97
Current: 0.9
-0.2
1.97
ROE (%) 18.80
MCK's ROE (%) is ranked higher than
82% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.65 vs. MCK: 18.80 )
Ranked among companies with meaningful ROE (%) only.
MCK' s 10-Year ROE (%) Range
Min: -3.01  Med: 15.94 Max: 22.45
Current: 18.8
-3.01
22.45
ROA (%) 3.05
MCK's ROA (%) is ranked lower than
66% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.31 vs. MCK: 3.05 )
Ranked among companies with meaningful ROA (%) only.
MCK' s 10-Year ROA (%) Range
Min: -0.9  Med: 4.01 Max: 7.46
Current: 3.05
-0.9
7.46
ROC (Joel Greenblatt) (%) 110.99
MCK's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.30 vs. MCK: 110.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MCK' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4.82  Med: 56.83 Max: 183.42
Current: 110.99
-4.82
183.42
Revenue Growth (3Y)(%) 15.90
MCK's Revenue Growth (3Y)(%) is ranked higher than
71% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.80 vs. MCK: 15.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MCK' s 10-Year Revenue Growth (3Y)(%) Range
Min: -7.8  Med: 11.60 Max: 26.5
Current: 15.9
-7.8
26.5
EBITDA Growth (3Y)(%) 16.70
MCK's EBITDA Growth (3Y)(%) is ranked higher than
68% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. MCK: 16.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MCK' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -52.7  Med: 11.90 Max: 171.6
Current: 16.7
-52.7
171.6
EPS Growth (3Y)(%) 10.50
MCK's EPS Growth (3Y)(%) is ranked higher than
50% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. MCK: 10.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MCK' s 10-Year EPS Growth (3Y)(%) Range
Min: -44.5  Med: 12.30 Max: 87.1
Current: 10.5
-44.5
87.1
» MCK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

MCK Guru Trades in Q3 2014

Louis Moore Bacon 40,000 sh (New)
Jeremy Grantham 227,600 sh (+2373.91%)
Ray Dalio 17,713 sh (+339.53%)
Lee Ainslie 1,857,273 sh (+7.99%)
Pioneer Investments 464,393 sh (unchged)
Joel Greenblatt Sold Out
Leon Cooperman 652,175 sh (-2.63%)
Scott Black 43,133 sh (-3.16%)
Mario Gabelli 14,040 sh (-3.57%)
Vanguard Health Care Fund 6,342,800 sh (-3.66%)
Larry Robbins 1,866,966 sh (-34.21%)
Paul Tudor Jones 50,000 sh (-36.96%)
Jim Simons 161,100 sh (-65.12%)
Steven Cohen 85,100 sh (-71.77%)
» More
Q4 2014

MCK Guru Trades in Q4 2014

Ken Fisher 967 sh (New)
Ray Dalio 22,313 sh (+25.97%)
Mario Gabelli 17,490 sh (+24.57%)
Leon Cooperman 715,203 sh (+9.66%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Pioneer Investments 463,990 sh (-0.09%)
Scott Black 38,844 sh (-9.94%)
Larry Robbins 1,352,460 sh (-27.56%)
Lee Ainslie 1,307,419 sh (-29.61%)
Steven Cohen 15,000 sh (-82.37%)
» More
Q1 2015

MCK Guru Trades in Q1 2015

Daniel Loeb 625,600 sh (New)
Daniel Loeb 625,600 sh (New)
Paul Tudor Jones 5,179 sh (New)
Joel Greenblatt 1,702 sh (New)
Ray Dalio 53,313 sh (+138.93%)
Pioneer Investments 467,336 sh (+0.72%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Ken Fisher Sold Out
Mario Gabelli 17,485 sh (-0.03%)
Scott Black 38,776 sh (-0.18%)
Leon Cooperman 699,203 sh (-2.24%)
Larry Robbins 1,243,960 sh (-8.02%)
Steven Cohen 7,200 sh (-52.00%)
Lee Ainslie 432,691 sh (-66.90%)
» More
Q2 2015

MCK Guru Trades in Q2 2015

Jim Simons 546,400 sh (New)
Andreas Halvorsen 625,568 sh (New)
Joel Greenblatt 229,882 sh (+13406.58%)
Paul Tudor Jones 6,881 sh (+32.86%)
Pioneer Investments 476,784 sh (+2.02%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Steven Cohen Sold Out
Daniel Loeb Sold Out
Lee Ainslie Sold Out
Mario Gabelli 17,300 sh (-1.06%)
Scott Black 38,358 sh (-1.08%)
Leon Cooperman 691,603 sh (-1.09%)
Larry Robbins 1,025,749 sh (-17.54%)
Ray Dalio 29,713 sh (-44.27%)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about McKesson Corp

Weekly Insider Sells Highlight: MCK, FEYE, GOOG, CI
According to GuruFocus Insider Data, the largest insider sells during the past week were: McKesson Corp, FireEye Inc, Google Inc, and Cigna Corp. Read more...
Leon Cooperman's Top Growth Stocks
Leon Cooperman (Trades, Portfolio)'s firm Omega Advisors is one of the largest hedge funds that has maintained a quarter over quarter turnover around 17%. Even in 2008 during the financial crisis, Cooperman was able to beat the market by staying away from the financial stocks. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 28.58
MCK's P/E(ttm) is ranked lower than
68% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.20 vs. MCK: 28.58 )
Ranked among companies with meaningful P/E(ttm) only.
MCK' s 10-Year P/E(ttm) Range
Min: 8.15  Med: 18.09 Max: 38.36
Current: 28.58
8.15
38.36
Forward P/E 15.85
MCK's Forward P/E is ranked lower than
53% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.61 vs. MCK: 15.85 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 24.50
MCK's PE(NRI) is ranked lower than
55% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.30 vs. MCK: 24.50 )
Ranked among companies with meaningful PE(NRI) only.
MCK' s 10-Year PE(NRI) Range
Min: 8.17  Med: 18.05 Max: 33.78
Current: 24.5
8.17
33.78
P/B 5.27
MCK's P/B is ranked lower than
77% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. MCK: 5.27 )
Ranked among companies with meaningful P/B only.
MCK' s 10-Year P/B Range
Min: 1.29  Med: 2.65 Max: 6.98
Current: 5.27
1.29
6.98
P/S 0.26
MCK's P/S is ranked higher than
76% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.06 vs. MCK: 0.26 )
Ranked among companies with meaningful P/S only.
MCK' s 10-Year P/S Range
Min: 0.08  Med: 0.18 Max: 0.32
Current: 0.26
0.08
0.32
PFCF 16.63
MCK's PFCF is ranked higher than
58% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.16 vs. MCK: 16.63 )
Ranked among companies with meaningful PFCF only.
MCK' s 10-Year PFCF Range
Min: 4.69  Med: 11.65 Max: 41.74
Current: 16.63
4.69
41.74
POCF 13.89
MCK's POCF is ranked higher than
59% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.72 vs. MCK: 13.89 )
Ranked among companies with meaningful POCF only.
MCK' s 10-Year POCF Range
Min: 4.25  Med: 9.63 Max: 88.45
Current: 13.89
4.25
88.45
EV-to-EBIT 15.52
MCK's EV-to-EBIT is ranked lower than
52% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.08 vs. MCK: 15.52 )
Ranked among companies with meaningful EV-to-EBIT only.
MCK' s 10-Year EV-to-EBIT Range
Min: -118.3  Med: 11.30 Max: 22.6
Current: 15.52
-118.3
22.6
PEG 1.55
MCK's PEG is ranked higher than
62% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.72 vs. MCK: 1.55 )
Ranked among companies with meaningful PEG only.
MCK' s 10-Year PEG Range
Min: 0.16  Med: 1.20 Max: 4.79
Current: 1.55
0.16
4.79
Shiller P/E 34.42
MCK's Shiller P/E is ranked lower than
63% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.69 vs. MCK: 34.42 )
Ranked among companies with meaningful Shiller P/E only.
MCK' s 10-Year Shiller P/E Range
Min: 12.51  Med: 25.20 Max: 43.35
Current: 34.42
12.51
43.35
Current Ratio 1.11
MCK's Current Ratio is ranked lower than
83% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.61 vs. MCK: 1.11 )
Ranked among companies with meaningful Current Ratio only.
MCK' s 10-Year Current Ratio Range
Min: 1.08  Med: 1.28 Max: 1.71
Current: 1.11
1.08
1.71
Quick Ratio 0.68
MCK's Quick Ratio is ranked lower than
90% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.11 vs. MCK: 0.68 )
Ranked among companies with meaningful Quick Ratio only.
MCK' s 10-Year Quick Ratio Range
Min: 0.52  Med: 0.66 Max: 0.92
Current: 0.68
0.52
0.92
Days Inventory 31.06
MCK's Days Inventory is ranked higher than
75% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 50.52 vs. MCK: 31.06 )
Ranked among companies with meaningful Days Inventory only.
MCK' s 10-Year Days Inventory Range
Min: 29.7  Med: 32.98 Max: 44.87
Current: 31.06
29.7
44.87
Days Sales Outstanding 33.36
MCK's Days Sales Outstanding is ranked higher than
76% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.91 vs. MCK: 33.36 )
Ranked among companies with meaningful Days Sales Outstanding only.
MCK' s 10-Year Days Sales Outstanding Range
Min: 18.94  Med: 26.68 Max: 32.36
Current: 33.36
18.94
32.36

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.48
MCK's Dividend Yield is ranked lower than
91% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.69 vs. MCK: 0.48 )
Ranked among companies with meaningful Dividend Yield only.
MCK' s 10-Year Dividend Yield Range
Min: 0.35  Med: 0.65 Max: 1.42
Current: 0.48
0.35
1.42
Dividend Payout 0.12
MCK's Dividend Payout is ranked higher than
93% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.35 vs. MCK: 0.12 )
Ranked among companies with meaningful Dividend Payout only.
MCK' s 10-Year Dividend Payout Range
Min: 0.04  Med: 0.14 Max: 6
Current: 0.12
0.04
6
Dividend growth (3y) 6.30
MCK's Dividend growth (3y) is ranked lower than
84% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.00 vs. MCK: 6.30 )
Ranked among companies with meaningful Dividend growth (3y) only.
MCK' s 10-Year Dividend growth (3y) Range
Min: -21.7  Med: 0.00 Max: 44.2
Current: 6.3
-21.7
44.2
Yield on cost (5-Year) 0.88
MCK's Yield on cost (5-Year) is ranked lower than
89% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.64 vs. MCK: 0.88 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MCK' s 10-Year Yield on cost (5-Year) Range
Min: 0.64  Med: 1.19 Max: 2.59
Current: 0.88
0.64
2.59
Share Buyback Rate 2.20
MCK's Share Buyback Rate is ranked higher than
83% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.60 vs. MCK: 2.20 )
Ranked among companies with meaningful Share Buyback Rate only.
MCK' s 10-Year Share Buyback Rate Range
Min: 4.3  Med: -0.50 Max: -43.4
Current: 2.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.18
MCK's Price/Projected FCF is ranked higher than
77% of the 22 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.37 vs. MCK: 1.18 )
Ranked among companies with meaningful Price/Projected FCF only.
MCK' s 10-Year Price/Projected FCF Range
Min: 0.55  Med: 1.05 Max: 17.04
Current: 1.18
0.55
17.04
Price/DCF (Earnings Based) 3.12
MCK's Price/DCF (Earnings Based) is ranked lower than
100% of the 6 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.27 vs. MCK: 3.12 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.44
MCK's Price/Median PS Value is ranked lower than
76% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.07 vs. MCK: 1.44 )
Ranked among companies with meaningful Price/Median PS Value only.
MCK' s 10-Year Price/Median PS Value Range
Min: 0.01  Med: 1.02 Max: 4.22
Current: 1.44
0.01
4.22
Price/Peter Lynch Fair Value 1.46
MCK's Price/Peter Lynch Fair Value is ranked higher than
57% of the 14 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. MCK: 1.46 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MCK' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.34  Med: 1.19 Max: 72.67
Current: 1.46
0.34
72.67
Earnings Yield (Greenblatt) (%) 6.43
MCK's Earnings Yield (Greenblatt) (%) is ranked higher than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.80 vs. MCK: 6.43 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MCK' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 4.4  Med: 8.60 Max: 16.5
Current: 6.43
4.4
16.5
Forward Rate of Return (Yacktman) (%) 21.46
MCK's Forward Rate of Return (Yacktman) (%) is ranked higher than
68% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.35 vs. MCK: 21.46 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MCK' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -34.2  Med: 19.80 Max: 102.1
Current: 21.46
-34.2
102.1

Analyst Estimate

Mar16 Mar17 Mar18
Revenue(Mil) 192,006 203,741 217,418
EPS($) 12.55 14.64 17.19
EPS without NRI($) 12.55 14.64 17.19

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:MCK.Mexico, MCK.Germany,
McKesson Corporation is a Delaware Corporation. The Company delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers from North America. McKesson Distribution Solutions consists of the following businesses: North America pharmaceutical distribution and services, International pharmaceutical distribution and services and Medical Surgical distribution and services. The Company competes with other software services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, payers, care management organizations, hardware vendors and internet-based companies with technology applicable to the healthcare industry.
» More Articles for MCK

Headlines

Articles On GuruFocus.com
The Case for Investing in AmerisourceBergen Aug 13 2015 
Weekly Insider Sells Highlight: MCK, FEYE, GOOG, CI Jul 21 2015 
Manson Creek Appoints Cornell McDowell as a Director and Provides Summer Exploration Update on the T Jul 14 2015 
Litespeed Management adds to its stake in MedAssets Jul 07 2015 
Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015 
Rite Aid – What To Expect From Q4 And Full Fiscal Earnings Report Tomorrow Apr 07 2015 
Larry Robbins' Top Growth Stocks Mar 25 2015 
Leon Cooperman's Top Growth Stocks Mar 21 2015 
Rite Aid Corporation is a Buy Feb 19 2015 
Manson Creek Terminates Option on Uptown Gold Property, NWT Dec 22 2014 

More From Other Websites
McKesson Corporation to Present at the 2015 Morgan Stanley Global Healthcare Conference Aug 26 2015
McKesson Corporation to Present at the 2015 Morgan Stanley Global Healthcare Conference Aug 26 2015
'Bottom fishing' market selloff: Pro Aug 25 2015
Cramer: The Fed needs to do this now Aug 20 2015
McKesson Selects Seal Software to Gain Unprecedented Visibility into Contracts and Reveal Key... Aug 19 2015
Quality Systems, Inc. Earnings Q2*, 2015 Aug 14 2015
The Case for Investing in AmerisourceBergen Aug 13 2015
McKesson Corporation -- Moody's moves McKesson's outlook to stable from negative; affirms Baa2 Aug 13 2015
UBS Makes Big Changes to Quality Growth at a Reasonable Price Portfolio Aug 11 2015
Dave Schulte to Join McKesson Ventures as Managing Director Aug 10 2015
McKesson Corp. Earnings Analysis: By the Numbers Q2*, 2015 Aug 07 2015
MCKESSON CORP Financials Aug 04 2015
UBS Makes August Changes to Equity Focus List Portfolio Aug 04 2015
ArcBest Corporation Names Two New Members to Board of Directors Aug 03 2015
MCKESSON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 03 2015
10-Q for McKesson Corp. Jul 31 2015
What the Boss Makes: CEO pay getting more ire from shareholders Jul 31 2015
MCKESSON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles... Jul 31 2015
McKesson (MCK) Tops Q1 Earnings, Ups Fiscal '16 Outlook - Analyst Blog Jul 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK